A 14-Year Retrospective Review of Angiosarcoma
Top Cited Papers
- 1 May 2005
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Cancer Journal
- Vol. 11 (3), 241-247
- https://doi.org/10.1097/00130404-200505000-00011
Abstract
Angiosarcoma is a rare vascular malignancy, and there are few published data to guide chemotherapy treatment decisions. We present a retrospective analysis of angiosarcoma encompassing all anatomic sites of disease presenting to a single institution over a 14-year period. Characteristics at presentation and prognostic factors are reviewed. For patients with unresectable disease, progression-free survival with various chemotherapy regimens is described. Pathological confirmation of all cases was performed before they were included in this analysis. One hundred twenty-five patients with angiosarcoma were seen and treated between January 1, 1990 and December 31, 2003. Angiosarcoma showed marked variation by anatomic site regarding gender ratio, median age at diagnosis, overall survival, and response to chemotherapy. Overall 5-year survival was 31% for angiosarcoma. Superficial depth and negative microscopic surgical margins correlated with longer overall survival, but tumor size did not reach significance as a prognostic factor. For unresectable angiosarcoma, doxorubicin-based regimens yielded progression-free survival of 3.7–5.4 months. Paclitaxel achieved a progression-free survival of 6.8 months for scalp angiosarcoma and 2.8 months for sites below the clavicle. Angiosarcoma is an aggressive malignancy characterized by biologic heterogeneity at different anatomic sites and relative sensitivity to paclitaxel and doxorubicin.Keywords
This publication has 20 references indexed in Scilit:
- Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicinBritish Journal of Dermatology, 2002
- Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapyZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Confirmed Angiosarcoma: Prognostic Factors and Outcome in 50 Prospectively Followed PatientsSarcoma, 2000
- Paclitaxel in the treatment of patients with angiosarcoma of the scalp or faceCancer, 1999
- Angiosarcomas of the head and neck: clinical and pathologic characteristics.Annals of Otology, Rhinology & Laryngology, 1997
- Angiosarcoma: A report of 67 patients and a review of the literatureCancer, 1996
- Angiosarcoma of the head and neckThe American Journal of Surgery, 1994
- Vascular Soft-Tissue SarcomasArchives of Surgery, 1991
- Angiosarcoma of the face and scalp, prognosis and treatmentCancer, 1987
- Angiosarcoma of skin and soft tissue: A study of forty-four casesCancer, 1981